Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 10/20 | 0.49 |
| ▸ | AURKB | Q96GD4 | 3/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | YES1 | P07947 | 1/20 | 0.43 |
| ▸ | HIPK1 | Q86Z02 | 1/20 | 0.43 |
| ▸ | PIM1 | P11309 | 1/20 | 0.42 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14097679 | 0.83 | ABL1 (0.59) | ABL1PIK3CA | |
| SCHEMBL14097682 | 0.83 | ABL1 (0.60) | ABL1MAPK1 | |
| SCHEMBL14097709 | 0.80 | PIK3CA (0.53) | ABL1PIK3CA | |
| SCHEMBL14097688 | 0.80 | ABL1 (0.49) | ABL1AURKBMAPK1YES1HIPK1 | |
| SCHEMBL14097583 | 0.76 | ABL1 (0.66) | ABL1 | |
| SCHEMBL1553491 | 0.75 | PIK3C3 (0.51) | ABL1MAPK1 | |
| SCHEMBL4078432 | 0.70 | — | — | |
| SCHEMBL14097700 | 0.69 | GAA (0.50) | ABL1 | |
| SCHEMBL2551061 | 0.69 | ABL1 (0.59) | ABL1MAPK1 | |
| SCHEMBL1553546 | 0.68 | ABL1 (0.53) | ABL1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7414046-B2 | Gyrase inhibitors and uses thereof | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2008-08-19 | — | — | US | disclosed |
| US-7414046-B2 | Gyrase inhibitors and uses thereof | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2008-08-19 | — | — | US | disclosed |
| US-RE40245-E1 | Gyrase inhibitors and uses thereof | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2008-04-15 | — | — | US | disclosed |
| US-RE40245-E1 | Gyrase inhibitors and uses thereof | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2008-04-15 | — | — | US | disclosed |
| EP-1341769-B1 | BACTERIAL GYRASE INHIBITORS AND USES THEREOF | VERTEX PHARMA (US) | 2007-10-17 | — | — | EP | disclosed |